To determine whether CD200 could indeed sufficiently cause NK cell apoptosis to account for their absence within the BCC TME, NKPOS cells were incubated with CD200 peptide in an Incucyte caspase 3 assay (Figure 4A). The gene discussed is CASP3; the disease is skin basal cell carcinoma.